11108 Federal Register / Vol. 60, No. 40 / Wednesday, March 1, 1995 / Notices

application was received and filed in

the Center for Drug Evaluation and

Research on December 27, 1994, which

shall be considered the filing date for

purposes of the act.

Interested persons may submit

relevant information on the application

to the Dockets Management Branch

(address above) in two copies (except

that individuals may submit single

copies) and identified with the docket

number found in brackets in the

heading of this document. These

submissions may be seen in the Dockets

Management Branch between 9 a.m. and

4 p.m., Monday through Friday.

The agency encourages any person

who submits relevant information on

the application to do so by March 13,

1995, and to provide an additional copy

of the submission directly to the contact

person identified above, to facilitate

consideration of the information during

the 30-day review period.

This notice is issued under the

Federal Food, Drug, and Cosmetic Act

(sec. 802 (21 U.S.C. 382)) and under

authority delegated to the Commissioner

of Food and Drugs (21 CFR 5.10) and

redelegated to the Center for Drug

Evaluation and Research (21 CFR 5.44).

Dated: February 9, 1995.

Edward Miracco,

Acting Deputy Director, Office of Compliance,

Center for Drug Evaluation and Research.

[FR Doc. 95–5059 Filed 2–28–95; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 95N–0049]

Drug Export; Zyloprim (Allopurinol

Sodium) for Injection Equivalent to 500

Milligrams Allopurinol Sterile

Lyophilized Powder

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Burroughs Wellcome Co. has filed

an application requesting approval for

the export of the human drug Zyloprim

(allopurinol sodium) for Injection

equivalent to 500 milligrams (mg)

allopurinol to Canada.

ADDRESSES: Relevant information on

this application may be directed to the

Dockets Management Branch (HFA–

305), Food and Drug Administration,

rm. 1–23, 12420 Parklawn Dr.,

Rockville, MD 20857, and to the contact

person identified below. Any future

inquiries concerning the export of

human drugs under the Drug Export

Amendments Act of 1986 should also be

directed to the contact person.

FOR FURTHER INFORMATION CONTACT:

James E. Hamilton, Center for Drug

Evaluation and Research (HFD–310),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–594–2073.

SUPPLEMENTARY INFORMATION: The drug

export provisions in section 802 of the

Federal Food, Drug, and Cosmetic Act

(the act) (21 U.S.C. 382) provide that

FDA may approve applications for the

export of drugs that are not currently

approved in the United States. Section

802(b)(3)(B) of the act sets forth the

requirements that must be met in an

application for approval. Section

802(b)(3)(C) of the act requires that the

agency review the application within 30

days of its filing to determine whether

the requirements of section 802(b)(3)(B)

have been satisfied. Section 802(b)(3)(A)

of the act requires that the agency

publish a notice in the Federal Register

within 10 days of the filing of an

application for export to facilitate public

participation in its review of the

application. To meet this requirement,

the agency is providing notice that

Burroughs Wellcome Co., 3030

Cornwallis Rd., P.O. Box 12700,

Research Triangle Park, NC 27709–2700,

has filed an application requesting

approval for the export of the human

drug Zyloprim (allopurinol sodium) for

Injection equivalent to 500 mg

allopurinol to Canada. This product is

primarily indicated for its prophylactic

usage in patients with leukemia,

lymphomas, or other malignancies,

receiving antineoplastic treatment

(radiation or cytotoxic drugs) which

might induce increased uric acid levels.

The firm does have new drug

application approval for Zyloprim

(allopurinol) Tablets in two dosage

strengths. The application was received

and filed in the Center for Drug

Evaluation and Research on January 25,

1995, which shall be considered the

filing date for purposes of the act.

Interested persons may submit

relevant information on the application

to the Dockets Management Branch

(address above) in two copies (except

that individuals may submit single

copies) and identified with the docket

number found in brackets in the

heading of this document. These

submissions may be seen in the Dockets

Management Branch between 9 a.m. and

4 p.m., Monday through Friday.

The agency encourages any person

who submits relevant information on

the application to do so by March 13,

1995, and to provide an additional copy

of the submission directly to the contact

person identified above, to facilitate

consideration of the information during

the 30-day review period.

This notice is issued under the

Federal Food, Drug, and Cosmetic Act

(sec. 802 (21 U.S.C. 382)) and under

authority delegated to the Commissioner

of Food and Drugs (21 CFR 5.10) and

redelegated to the Center for Drug

Evaluation and Research (21 CFR 5.44).

Dated: February 8, 1995.

Edward Miracco,

Acting Deputy Director, Office of Compliance,

Center for Drug Evaluation and Research.

[FR Doc. 95–5062 Filed 2–28–95; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[NM–070–5101–G014; NMNM93652]

Notice of intent, and Notice of Scoping

Meetings and Comment Period; New

Mexico

AGENCY: Bureau of Land Management,

Interior.

ACTION: Notice of intent, and notice of

scoping meetings with a public

comment period.

SUMMARY: In accordance with the

National Environmental Policy Act, the

Bureau of Land Management is directing

the preparation of an environmental

document for the construction,

operation, and maintenance of a

pipeline that would be 12 or 16 inches

in diameter and approximately 400

miles in length. The proposed project is

known as the Mid-American Pipeline

Company Four Corners Loop Project.

The environmental document is being

prepared as an environmental

assessment, but will be advanced to the

environmental impact statement level if

this is indicated by scoping or by a

determination of significant impacts in

the environmental assessment. Public

meetings will be held for the proposed

pipeline project with a public comment

period.

DATES: Public scoping meetings are

planned in Albuquerque, New Mexico

at the Albuquerque Convention Center,

San Miguel Room, 401 Second Street,

NW., on March 15, 1995 at 3:00 p.m. to

9:00 p.m. and in Roswell, New Mexico

at the Roswell Inn, Berrendo Room,

1815 North Main at 3:00 p.m. to 9:00

p.m. on March 16, 1995, respectively.

The meeting agenda will be to conduct

an open-house to receive interested

parties from 3:00 p.m. to 5:30 p.m. with

a formal presentation starting at 7:00

p.m., followed by a workshop to receive

comments, and ending at 9:00 p.m.
Federal Register / Vol. 60, No. 40 / Wednesday, March 1, 1995 / Notices 11109

Written comments on the proposed

project accepted until March 31, 1995.

ADDRESSES: Any comments should be

sent to the Bureau of Land Management,

Farmington District Office, Attention:

Jerry Crockford, 1235 LaPlata Highway,

Farmington, NM 87401.

FOR FURTHER INFORMATION CONTACT: Jerry

Crockford, (505) 599–6333.

SUPPLEMENTARY INFORMATION: Pursuant

to Section 28 of the Mineral Leasing Act

of 1920 (30 U.S.C.), as amended by the

Act of November 16, 1973 (37 Stat. 567),

the Mid-America Pipeline Company has

applied for a right-of-way, serial number

NMNM93652, for the construction,

operation, and maintenance of a

pipeline. The proposed project crosses

Federal, State, Indian, and private land.

The pipeline starts at the Chaco Pump

Station approximately 12 miles south of

Farmington, New Mexico and ends at

the Mid-American Pipeline Company

Hobbs Pump Station located in Texas

southeast of Hobbs, New Mexico. The

proposed project will parallel existing

pipelines for most of its length except as

dictated by resource conflicts. The

pipeline is designed to transport 50,000

barrels of natural gas liquids per day.

Maps of the Mid-America Pipeline

Company proposed route are available

for viewing at the Bureau of Land

Management, Albuquerque District

Office, 435 Montano NE., Albuquerque,

New Mexico; Farmington District Office,

1235 LaPlata Highway, Farmington,

New Mexico; Roswell District Office,

1717 West Second, Roswell, New

Mexico; Carlsbad Resource Area Office,

620 East Greene, Carlsbad, New Mexico.

Dated: February 23, 1995.

Joel E. Farrell,

Assistant District Manager for Lands and

Renewable Resources.

[FR Doc. 95–5046 Filed 2–28–95; 8:45 am]

BILLING CODE 4310–FB–M

Fish and Wildlife Service

Notice of Receipt of Applications for

Permit

The following applicants have

applied for a permit to conduct certain

activities with endangered species. This

notice is provided pursuant to Section

10(c) of the Endangered Species Act of

1973, as amended (16 U.S.C. 1531, et

seq.):

Applicant: S.O.S. Care, Escondido, CA,

PRT–796422

The applicant requests a permit to

import and reexport newborn-captiveborn tigrina (Felis tigrina) from the

Conservation Project at the Sao Paulo

Zoo, Sao Paulo, Brazil for medical

treatment for the purpose of

enhancement of survival of the species.

Applicant: Zoological Society of San

Diego, San Diego, CA, PRT–799314

The applicant requests a permit to

export DNA samples from captive-born

lowland tapir (Tapirus terrestris),

Turkmanian kulan (Equus hemionus

kulan), Somali wild ass (Equus

africanus somalicus) and Przewalski’s

wild horse (Equus przewalskii) for the

purpose of scientific research.

Applicant: International Crane

Foundation, Baraboo, WI, PRT–799313

The applicant requests a permit to

export 8 captive-produced eggs of redcrowned crane (Grus japonensis) and 8

captive-produced eggs of white-naped

crane (Grus vipio) to V.A. Andronov,

Khinganski Nature Reserve, Amurskaja

Reg., Russia for the purpose of

enhancement and propagation of the

species through rearing and

reintroduction to the wild.

Applicant: International Crane

Foundation, Baraboo, WI, PRT–799312

The applicant requests a permit to

export up to 10 captive-produced eggs

of Siberian crane (Grus leucogeranus) to

Oka State Nature Reserve, Spasski

Region, Rjazan Oblast, Russia for the

purpose of enhancement and

propagation of the species through

rearing and reintroduction to the wild.

Applicant: International Fisheries, Inc.,

Hialeah, FL, PRT–798217

The applicant requests a permit to

import up to 2,000 captive-bred Asian

bonytongue (Scleropages formosus)

from the Rainbow Aquarium in

Singapore for the purpose of

enhancement of survival of the species.

Applicant: National Zoological Park,

Washington, D.C., PRT–700309

The applicant requests a permit to

take, import, export, reexport and

purchase in interstate and foreign

commerce, blood, hair and other tissue

samples, and salvaged carcasses from

any endangered wildlife exotic to the

United States for the purpose of

scientific research to enhance the

survival of endangered species in the

wild. Tissues are to be obtained from

animals in the wild and in zoos. Tissues

collected from animals in the wild are

to be collected opportunistically during

immobilization of the animals by local

wildlife management officials. Wild

animals will be immobilized, but not

harmed, for collection of tissues.

Written data or comments should be

submitted to the Director, U.S. Fish and

Wildlife Service, Office of Management

Authority, 4401 North Fairfax Drive,

Room 420(c), Arlington, Virginia 22203

and must be received by the Director

within 30 days of the date of this

publication.

Documents and other information

submitted with these applications are

available for review, subject to the

requirements of the Privacy Act and

Freedom of Information Act, by any

party who submits a written request for

a copy of such documents to the

following office within 30 days of the

date of publication of this notice: U.S.

Fish and Wildlife Service, Office of

Management Authority, 4401 North

Fairfax Drive, Room 420(c), Arlington,

Virginia 22203. Phone: (703/358–2104);

FAX: (703/358–2281).

Dated: February 24, 1995.

Caroline Anderson,

Acting Chief, Branch of Permits, Office of

Management Authority.

[FR Doc. 95–5045 Filed 2–28–95; 8:45 am]

BILLING CODE 4310–55–P

National Park Service

Notice of Intent To Repatriate a

Cultural Item in the Possession of the

Field Museum of Natural History,

Chicago, IL

AGENCY: National Park Service, Interior.

ACTION: Notice.

Notice is hereby given under the

Native American Graves Protection and

Repatriation Act of 1990 of the intent to

repatriate an item in the possession of

the Field Museum of Natural History,

Chicago, IL, under a compromise of

repatriation claim.

The item is a wampum belt consisting

of purple and white shell beads woven

into a 32’’ long by 5’’ wide rectangular

panel. The beads are placed to form a

series of diamond-shaped figures inside

oblongs. The belt is bound with

buckskin with buckskin fringe attached

at the ends. The belt was purchased by

the Field Museum from Walter C.

Wyman in December 1900 (FM# 68566).

Museum records indicate that the belt

was originally purchased by Wyman

from the grandson of Chief Skenandoa

on May 8, 1898, approximately one year

after the chief’s death.

Authorized representatives of the

Oneida Indian Nation of New York and

the Oneida Tribe of Indians of

Wisconsin have been provided with

copies of museum records and

photographs of the belt. In a letter dated

February 7, 1994, the Oneida Indian